Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Chirag B. Patel Image

      Chirag B. Patel, MD, PhD

      Department of Neuro-Oncology, Division of Cancer Medicine

      Present Title & Affiliation

      Primary Appointment

      Cancer Biology Program Faculty (Joint appointment), The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS), Houston, TX

      Neuroscience Graduate Program Faculty (Joint appointment), The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS), Houston, TX

      Assistant Professor, Neuro-Oncology, Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

      McNair Scholar, McNair Medical Institute at The Robert and Janice McNair Foundation, Houston, TX

      Dual/Joint/Adjunct Appointment

      Cancer Biology Program Faculty, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS), Houston, Texas

      Neuroscience Graduate Program Faculty, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS), Houston, Texas

      Assistant Professor, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Education & Training

      Degree-Granting Education

      2012The University of Texas at Houston John P. and Kathrine G. McGovern Medical School, Houston, Texas, US, Medicine, MD
      2010The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, US, Biomedical Sciences, PhD
      2004Johns Hopkins University, Baltimore, Maryland, US, Biomedical Engineering, MSE
      2001Johns Hopkins University, Baltimore, Maryland, US, Biomedical Engineering, BS

      Postgraduate Training

      2018-2019Clinical Fellowship, Neuro-Oncology, Stanford University School of Medicine, Stanford, California
      2016-2019Postdoctoral Research Fellowship, Multimodal Molecular Imaging, Stanford University School of Medicine, Stanford, California
      2013-2016Clinical Residency, Neurology, University of California at Los Angeles David Geffen School of Medicine, Los Angeles, California
      2012-2013Clinical Internship, Internal Medicine, East Tennessee State University Quillen College of Medicine, Johnson City, Tennessee

      Licenses & Certifications

      2025Texas Medical License

      Experience & Service

      Faculty Academic Appointments

      Clinical Assistant Professor, Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, 2019 - 2021

      Clinical Assistant Professor, Department of Radiology, Stanford University School of Medicine, Stanford, California, 2019 - 2021

      Clinical Instructor, Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, 2019 - 2019

      Administrative Appointments/Responsibilities

      Fellowship Program Director, Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, 2021 - 2021

      Resident Education Director, Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, 2020 - 2021

      Other Professional Positions

      Associate Member, Stanford Cancer Institute (Cancer Imaging and Early Detection Program), Stanford Cancer Institute, Stanford, California, 2020 - 2021

      Faculty Affiliate, Stanford Artificial Intelligence in Medicine and Imaging (AIMI) Center, Stanford University, Stanford, California, 2020 - 2021

      Affiliated Faculty Member, Stanford University Wu Tsai Neurosciences Institute, Stanford University, Stanford, California, 2019 - 2021

      Intramural Institutional Committee Activities

      Member, Admissions Committee, Medical Scientist Training Program (MSTP) MD/PhD Admissions Committee, The University of Texas Medical Scientist Training Program at Houston (MD/PhD Program of the University of Texas Health Science Center at Houston & The University of Texas MD Anderson Cancer Center), 2023 - Present

      Editorial Activities

      Editorial Board Member, BMC Neuroscience, 2021 - Present

      Honors & Awards

      2022 - 2023McNair Scholar, McNair Medical Institute at The Robert and Janice McNair Foundation
      202040 Under 40 in Cancer Rising Stars and Emerging Leaders, The Lynx Group, Upstream Partners, Swim Across America, and The National Community Oncology Dispensing Association, Inc. (NCODA)
      2019Young Investigators Forum in Neuro-Oncology, Society for Neuro-Oncology (SNO) and WebMD Professional Independent Medical Education (prIME) Oncology
      2019Theodore Segal Endowed Lecture, University of Louisville School of Medicine
      2018Young Investigator Palatucci Research Award, California Neurology Society
      2015 - 2016Neurologist-In-Training Clinical Ethics Elective, American Academy of Neurology (AAN)
      2009Dee S. and Patricia Osborne Endowed Scholarship in the Neurosciences, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences
      2008Tzu Chi Scholarship Award for Excellence, University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS)
      2007Toshi Nikaidoh Leadership and Service Scholarship Award, University of Texas Health Science Center at Houston (UTHSCH) Student InterCouncil
      2005Excellence in Medicine Leadership Award, American Medical Association Foundation
      2004Physician Oncology Education Program (POEP) Medical Student Scholarship, Texas Medical Association
      2002Governor's Volunteer & Service Award, Maryland Governor's Office on Service & Volunteerism
      2002Martin Luther King, Jr. Award for Community Service, Johns Hopkins University

      Professional Memberships

      American Association for Cancer Research (AACR)

      2016 - Present

      American Society of Clinical Oncology (ASCO)

      2016 - Present

      Society for Neuro-Oncology (SNO)

      2014 - Present

      American Academy of Neurology (AAN)

      2010 - Present

      American Physician Scientists Association (APSA)

      2005 - Present

      Sigma Xi (ΣΞ)

      2005 - Present

      Selected Presentations & Talks

      Local Presentations

      1. 2019. Increasing Glioblastoma Cell Membrane Permeability with Tumor Treating Fields. Invited. Theodore Segal Endowed Lecture. Louisville, KY, US.

      National Presentations

      1. 2025. Brain Tumor Diagnosis in the Molecular Era: What the Neurosurgeon and Neuro-Oncologist Need to Know. United States and Canadian Academy of Pathologists (USCAP) Annual Meeting. Boston, Massachusetts, US.
      2. 2025. “Tumor Implantation and Alternating Electric Field Treatment Testing in Rats,” Minisymposium on Physical and Computational Modeling of Glioblastoma Multiforme Treatment in Rats,. Society for Industrial and Applied Mathematics (SIAM) Conference on Computational Science and Engineering (CSE). Forth Worth, Texas, US.
      3. 2025. “Dynamic Contrast-enhanced MRI Processing Comparison for Distinguishing True Progression From Pseudoprogression in High-grade Glioma,” Biomarkers for Prognosis and Treatment Monitoring session, Neuro-Oncology Track. Society for Brain Mapping and Therapeutics (SBMT) Annual World Congress. Los Angeles, California, US.
      4. 2025. “Biological Therapies for Gliomas,” Scientific/Clinical Updates: Low and High Grade Gliomas session, Neuro-Oncology Track. Society for Brain Mapping and Therapeutics (SBMT) Annual World Congress. Los Angeles, California, US.
      5. 2025. Discussion on Current and Future Directions in Brain Cancer, Diagnosis, and Treatment plenary session. Society for Brain Mapping and Therapeutics (SBMT) Annual World Congress. Los Angeles, California, US.
      6. 2025. Benign Brain Tumors tumor board session, Neuro-Oncology Track. Society for Brain Mapping and Therapeutics (SBMT) Annual World Congress. Los Angeles, California, US.
      7. 2025. Artificial Intelligence (AI) in Bedside Monitoring session. Technology in Healthcare: Integration, Networks, and Knowledge (THINK) AI Healthcare Conference. Stanford, California, US.
      8. 2024. “Effects of therapeutic alternating electric fields on blood-brain barrier permeability in glioblastoma: collateral benefits?,”. Annual Cancer Neuroscience Symposium. Houston, Texas, US.
      9. 2023. Brain Tumor Diagnosis in the Molecular Era: What the Neurosurgeon and Neuro-Oncologist Need to Know. College of American Pathologists (CAP) Annual Meeting. Chicago, Illinois, US.

      International Presentations

      1. 2021. In Transition: From Early-career Researcher to Leader. Invited. American Association for Cancer Research (AACR) Career Discussions.
      2. 2019. Identification of a New Mechanism for how Tumor Treating Fields Affect Tumor Cells. Invited. American Association for Cancer Research (AACR) Annual Meeting Session ADT16 - Tumor Treating Fields: A Fourth Modality in Cancer Treatment. Atlanta, US.
      Read More
      Less

      Grant & Contract Support

      Date: 2026 - 2027
      Title:Miniaturized probe to measure the therapeutic electric fields dose in pre-clinical models of glioblastoma
      Funding Source:CPRIT
      Role:Co-I
      ID:RP260798
      Date: 2023 - 2025
      Title:Cancer Neuroscience Program Research Grant
      Funding Source:The University of Texas MD Anderson Cancer Center (MDACC) Cancer Neuroscience Program (CNP)
      Role:Co-PI
      Date: 2023 - 2024
      Title:Glioblastoma Moon Shot Grant
      Funding Source:The University of Texas MD Anderson Cancer Center (MDACC) Glioblastoma Moon Shot
      Role:Co-PI
      Date: 2022 - Present
      Title:McNair Scholar
      Funding Source:McNair Medical Institute at The Robert and Janice McNair Foundation
      Role:PI
      ID:05-Patel,Chirag
      Date: 2022 - 2025
      Title:AACR-Novocure Career Development Award for Tumor Treating Fields (TTFields) Research
      Funding Source:American Association for Cancer Research (AACR)
      Role:PI
      ID:22-20-62-PATE
      Date: 2022 - 2024
      Title:Developmental Research Project Grant
      Funding Source:The University of Texas MD Anderson Cancer Center Brain Cancer SPORE Grant
      Role:PI
      Date: 2021 - 2023
      Title:Translational Research Program Pilot Grant
      Funding Source:Stanford SPARK Program in Translational Research
      Role:Co-PI
      ID:N/A
      Date: 2021 - 2022
      Title:Neuroscience:Translate Grant
      Funding Source:Stanford Wu Tsai Neurosciences Institute
      Role:PI
      ID:N/A
      Date: 2020 - 2021
      Title:Google Cloud Platform (GCP) Award
      Funding Source:Stanford Center for Artificial Intelligence in Medicine and Imaging (AIMI) -
      Role:PI
      ID:N/A
      Date: 2019 - 2021
      Title:Postdocs at the Interface Seed Grant
      Funding Source:Stanford Chemistry, Engineering & Medicine for Human Health (ChEM-H)
      Role:Co-PI
      ID:N/A
      Date: 2019 - 2021
      Title:Extramural Loan Repayment Program for Clinical Researchers (LRP-CR)
      Funding Source:NIH
      Role:PI
      ID:N/A
      Date: 2019 - 2020
      Title:Testing Molecular Hypotheses in Human Subjects Seed Grant
      Funding Source:Stanford Chemistry, Engineering & Medicine for Human Health (ChEM-H)
      Role:Investigator
      ID:N/A
      Date: 2017 - 2019
      Title:Basic Research Fellowship supported by the Ryan J. Hanrahan Memorial
      Funding Source:American Brain Tumor Association
      Role:PI
      ID:BRF1700008
      Date: 2017 - 2018
      Title:Fellowship Award for Cancer Research
      Funding Source:Stanford Cancer Institute
      Role:PI
      ID:N/A
      Date: 2016 - 2018
      Title:Stanford Society of Physician Scholars Grant
      Funding Source:Stanford University School of Medicine
      Role:Co-PI
      ID:N/A
      Date: 2016 - 2017
      Title:NIH NINDS Research Education Grant (R25) Programs for Residents and Fellows in Neurology, Neurosurgery, Neuropathology, and Neuroradiology
      Funding Source:NIH/NINDS
      Role:Trainee
      ID:5R25NS065741-07
      Date: 2015 - 2016
      Title:Research Seed Grant
      Funding Source:American Medical Association Foundation
      Role:PI
      ID:N/A
      Date: 2015 - 2016
      Title:Research Education Grant (R25) Programs for Residents and Fellows in Neurology, Neurosurgery, Neuropathology, and Neuroradiology
      Funding Source:NIH/NINDS
      Role:Trainee
      ID:2 R25 NS 065723 06

      Selected Publications

      Peer-Reviewed Articles

      1. Wang L, Xiang J, Li L, Liu Y, Chen L, Wang R, Ling X, Li Z, Patel CB, Baum RP, Jia W, Zhang J, Zhu Z, Chen X, Li D. Antitumor efficacy and safety of locoregional [177Lu]Lu-RM26 radionuclide therapy in glioblastoma. Eur J Nucl Med Mol Imaging, 2026. e-Pub 2026. PMID: 42301422.
      2. Pirhoushiaran, M, Walker-Charles, K, Yao, TH, Putluri, S, Patel, N, Wang, DH, Wang, I, Arjuna, S, Dono, A, Bueno, A, Nguyen, S, Balar, AP, Huse, J, Kundu, S, Esquenazi, Y, Patel, C, Prabhu, SS, Lang Jr, FF, Ballester, L. Exploring CSF microRNA signatures as diagnostic biomarkers in adult-type diffuse gliomas. Non-coding RNA Research 18:22-38, 2026. e-Pub 2026. PMID: 41624475.
      3. Ciavarra B, Krayyem A, Ansari S, Shindell E, Gule-Monroe MK, Patel CB, Johnson JM. Delayed 18F-FDG PET for the Evaluation of Suspected Recurrent Disease in Brain Metastases Treated with Radiation. Clinical Radiology, 2026. e-Pub 2026.
      4. Arjuna S, Pirhoushiaran M, Bueno A, Sanchez-Espitia A, Tavakkol E, Khalaj K, Shah M, Wang I, Balar AP, Dono A, Duose D, Nguyen S, Kamali A, Luthra R, Patel CB, Prabhu SS, Lang FF, Esquenazi Y, Ballester LY. CSF ctDNA analysis guides molecular reclassification of diffuse glioma patients. J Neurooncol 178(1):14, 2026. e-Pub 2026. PMID: 42168657.
      5. Johnson JM, Rashiwala A, Krayyem A, Wang E, Farzaneh H, Pokhylevych H, Amer A, Layman R, Schellingerhout D, Patel CB. Timing and Energy Optimization of Dual-Energy CT for Brain Metastasis Conspicuity: A Prospective 24-Patient Study. J Comput Assist Tomogr, 2026. e-Pub 2026. PMID: 42023649.
      6. Khalaf A, Naya L, Flynt L, Surasi DS, Lu Y, Nagpal S, Thomas RP, Recht LD, Beckham TH, Liu HL, Davidzon G, Beinat C, Patel CB. [18F]DASA-23 PET/MRI evaluation in newly-diagnosed and recurrent high-grade glioma. Neuroradiology, 2026. e-Pub 2026. PMID: 41920333.
      7. Kamiya Matsuoka, C, Patel, CB, Battiste, JD. Application of 200 kHz Tumor Treating Fields (TTFields) in Patients With Infratentorial High-Grade Glioma. Brain Tumor Research and Treatment 14(2):109-115, 2026. e-Pub 2026. PMID: 42120300.
      8. Haisraely O, Tom MC, Perni S, Kudchadker R, Prajapati S, Zlateva Y, Weinberg JS, Yeboa DN, Li J, Ferguson SD, Alvarez-Breckenridge C, Patel CB, Ene CI, Prabhu S, Beckham TH. Cs-131 Collagen Tile Brachytherapy for Recurrent Glioblastoma: Treatment Outcomes and Toxicity. Pract Radiat Oncol 16(2):e101-e107, 2026. e-Pub 2026. PMID: 41360286.
      9. Yeboa, DN, Whitfield, BT, Lin, R, Ejezie, CL, Swanson, T, Beckham, TH, Wang, C, De, BS, Perni, S, Tom, MC, Li, J, McGovern, SL, Harrison, R, Majd, NK, Puduvalli, VK, Aaroe, AE, Loghin, ME, O'Brien, BJ, Patel, AD, Patel, C, Wefel, JS, Taslicay, CA, Gule-Monroe, MK, Paulino, AC, McAleer, MF, Grosshans, DR, Ghia, AJ, Jiang, W, Chung, C, Maor, MM, Yang, CH, Gubbiotti, M, Kamiya Matsuoka, C, Ballester, L, Weathers, S, Huse, J. Prospective phase II clinical trial of molecular glioblastoma (historical grade 2 and 3 IDH wildtype gliomas) preliminary novel exploratory analyses. Journal of neuro-oncology 176(1), 2026. e-Pub 2026. PMID: 41191157.
      10. Kim, KM, Cheetham-West, AO, Ahmed, MR, Phillips, M, Malkovskiy, AV, Pothineni, VR, Brewer, KD, Patel, C, Rajadas, J, Mahaney, KB. Intraventricular iron causes severe hydrocephalus – a model of severe neonatal hydrocephalus. Fluids and Barriers of the CNS 23(1), 2025. e-Pub 2025. PMID: 41444634.
      11. Neil, EC, Bruhnding, A, Ahmed, ZA, Kumthekar, P, Blondin, NA, Grommes, C, Patel, C, Hsu, SH, Wang, F, Miao, H, Rosen, NL, Halker Singh, RB, Burish, MJ, Corbin, ZA. Representation of neuro-oncology in American neurology departments. Neuro-Oncology Practice 12(6):1121-1129, 2025. e-Pub 2025. PMID: 41458932.
      12. Daling MH, Durfee D, Shelton T, Simonian S, Schubert K, Khan S, Patel CB, Leung VW. Sub-centimeter Probes for Low-Frequency Alternating Electric Field (AEF) Measurements in Rodent Models of Brain Cancer. Proceedings of the 2025 IEEE 21st International Conference on Body Sensor Networks (BSN), 2025. e-Pub 2025.
      13. Amer, A, Ansari, S, Krayyem, A, Kundu, S, Khose, S, Pokhylevych, H, Calle, S, Patel, C, Yang, Z, Liu, HL, Johnson, JM. Dynamic Contrast-enhanced MRI Processing Comparison for Distinguishing True Progression From Pseudoprogression in High-grade Glioma. Journal of computer assisted tomography 49(4):656-661, 2025. e-Pub 2025. PMID: 39876523.
      14. Abreu M, Patel CB, Patel K, Khawaja F, Tummala S. Progressive Multifocal Leukoencephalopathy in Chimeric Antigen Receptor T-Cell Therapy Recipients: A Case Study. J Adv Pract Oncol:1-10, 2025. e-Pub 2025. PMID: 40599195.
      15. Martinez Paniagua, M, Khan, S, Henning, NW, Konagalla, SV, Patel, C. Optimized Methods to Quantify Tumor Treating Fields (TTFields)-Induced Permeabilization of Glioblastoma Cell Membranes. Methods and Protocols 8(1), 2025. e-Pub 2025. PMID: 39997634.
      16. Lam, K, Ozkizilkaya, HI, Milton, D, Dono, A, Liu, Y, Kundu, S, Kumar, VA, Johnson, JM, Esquenazi, Y, Patel, C, Ballester, L. Molecular alterations in IDH-mutant astrocytoma. Neuro-Oncology Advances 7(1), 2025. e-Pub 2025. PMID: 40575414.
      17. Alhusaini, S, Naya, L, Reddy, SA, Patel, C. MEK Pathway Inhibitor-Mediated Response in BRAF V600-Mutant Melanoma with Brain Parenchymal and Leptomeningeal Metastases. Annals of Neurology 96(6):1227-1229, 2024. e-Pub 2024. PMID: 39324488.
      18. Wang, DH, Fujita, Y, Dono, A, Rodriguez-Armendariz, AG, Shah, M, Putluri, N, Pichardo-Rojas, PS, Patel, C, Zhu, JJ, Huse, J, Parker Kerrigan, BC, Lang Jr, FF, Esquenazi, Y, Ballester, L. The genomic alterations in glioblastoma influence the levels of CSF metabolites. Acta Neuropathologica Communications 12(1), 2024. e-Pub 2024. PMID: 38243318.
      19. Gregory, TA, Knight, SR, Aaroe, AE, Highsmith, KN, Janatpour, ZC, O’Brien, BJ, Majd, NK, Loghin, ME, Patel, C, Weathers, S, Puduvalli, VK, Kamiya Matsuoka, C. Accelerated tumor progression after COVID-19 infection in patients with glioblastoma. Neuro-Oncology Practice 11(4):475-483, 2024. e-Pub 2024. PMID: 39006516.
      20. Beckham, TH, Rooney, MK, McAleer, MF, Ghia, AJ, Tom, MC, Perni, S, McGovern, SL, Grosshans, DR, Chung, C, Wang, C, De, BS, Swanson, T, Paulino, AC, Jiang, W, Ferguson, SD, Patel, C, Li, J, Yeboa, DN. Hypofractionated radiotherapy for glioblastoma. Neuro-Oncology Practice 11(3):266-274, 2024. e-Pub 2024. PMID: 38737610.
      21. Ledbetter, D, de Almeida, R, Wu, X, Naveh, A, Patel, C, Gonzalez, Q, Beckham, TH, North, RY, Rhines, LD, Li, J, Ghia, AJ, Aten, D, Tatsui, CE, Alvarez-Breckenridge, C. Tumor treating fields suppress tumor cell growth and neurologic decline in models of spinal metastases. JCI Insight 9(9), 2024. e-Pub 2024. PMID: 38512420.
      22. Nguyen, H, Schubert, KE, Pohling, C, Chang, E, Yamamoto, V, Zeng, Y, Nie, Y, Van Buskirk, S, Schulte, R, Patel, C. Impact of glioma peritumoral edema, tumor size, and tumor location on alternating electric fields (AEF) therapy in realistic 3D rat glioma models: a computational study. Physics in medicine and biology 69(8), 2024. e-Pub 2024. PMID: 38417178.
      23. Yamin, G, Tranvinh, E, Lanzman, B, Tong, E, Hashmi, SS, Patel, C, Iv, M. Arterial Spin-Labeling and DSC Perfusion Metrics Improve Agreement in Neuroradiologists’ Clinical Interpretations of Posttreatment High-Grade Glioma Surveillance MR Imaging—An Institutional Experience. American Journal of Neuroradiology 45(4):453-460, 2024. e-Pub 2024. PMID: 38453410.
      24. Tatsui, CE, Carlson, KW, Patel, C. Tumor treating fields (TTFields) for spinal metastasis—The case for bone removal and spinal implants as waveguides to enhance field strength at the target. Neuro-Oncology Advances 6(1), 2024. e-Pub 2024. PMID: 38288093.
      25. Wang DH, Fujita Y, Rodríguez Armendáriz AG, Dono A, Shah M, Putluri N, Pichardo-Rojas PS, Patel CB, Huse JT, Zhu JJ, Parker Kerrigan BC, Lang FF, Esquenazi Y, Ballester LY. The Genomic Alterations in Glioblastoma Influence the Levels of CSF Metabolites. Acta Neuropathologica Communications, 2023. e-Pub 2023. PMID: 38243318.
      26. Iv M, Naya L, Sanan S, Van Buskirk SL, Nagpal S, Thomas R, Recht L, Patel CB. Tumor Treating Fields Increases Blood-Brain Barrier Permeability and Relative Cerebral Blood Volume in Patients with Glioblastoma. The Neuroradiology Journal 37(1):107-118, 2023. e-Pub 2023. PMID: 37931176.
      27. Nguyen H, Schubert KE, Chang E, Nie Y, Pohling C, Van Buskirk S, Yamamoto V, Zeng Y, Schulte RW, Patel CB. Electric field distributions in realistic 3D rat head models during alternating electric field (AEF) therapy: a computational study: a computational study. Physics in Medicine and Biology 68(20), 2023. e-Pub 2023. PMID: 37703902.
      28. Xiao, D, Yan, C, Li, D, Xi, T, Liu, XZ, Zhu, D, Huang, G, Xu, J, He, ZW, Wu, A, Ma, C, Long, J, Shu, K, Ji, H, Wang, N, Chen, G, Yang, J, Ma, H, Li, ZY, Sun, X, Qu, Y, Liu, Z, Jiang, X, Tian, C, Ni, S, Zhan, R, Chen, L, Ge, M, Wang, M, Jiang, X, Guo, G, Han, Z, Zhang, C, Zhang, T, Dou, C, Chu, L, Wang, P, Shao, J, Wu, X, Yu, J, Wang, Y, Wu, N, Zhang, R, Zhang, M, Hong, Y, Gao, J, Li, Y, Pan, Y, Zhao, B, Ji, N, Shan, GL, Patel, C, Jia, W, Zhang, LW. National Brain Tumour Registry of China (NBTRC) statistical report of primary brain tumours diagnosed in China in years 2019–2020. The Lancet Regional Health - Western Pacific 34, 2023. e-Pub 2023. PMID: 37283963.
      29. Pohling C, Nguyen H, Chang E, Schubert KE, Nie Y, Bashkirov V, Yamamoto V, Zeng Y, Stupp R, Schulte RW, Patel CB. Current status of the preclinical evaluation of alternating electric fields as a form of cancer therapy. Bioelectrochemistry 149, 2023. e-Pub 2023. PMID: 36306728.
      30. Xiao D, Yan C, Li D, Xi T, Liu X, Zhu D, Huang G, Xu J, He Z, Wu A, Ma C, Long J, Shu K, Ji H, Wang N, Chen G, Yang J, Ma H, Li Z, Sun X, Qu Y, Liu Z, Jiang X, Tian C, Ni S, Zhan R, Chen L, Ge M, Wang M, Jiang X, Guo G, Han Z, Zhang C, Zhang T, Dou C, Chu L, Wang P, Shao J, Wu X, Yu J, Wang Y, Wu N, Zhang R, Zhang M, Hong Y, Gao J, Li Y, Pan Y, Zhao B, Ji N, Shan G, Patel CB, Jia W, Zhang L. National Brain Tumor Registry of China (NBTRC) Statistical Report of Primary Brain Tumors Diagnosed in China in years 2019-2020. The Lancet Regional Health - Western Pacific, 2023. e-Pub 2023. PMID: 37283963.
      31. Wu, A, Huang, RJ, Colón, GR, Zembrzuski, C, Patel, C. Low rates of structured advance care planning documentation in electronic health records. BMC Palliative Care 21(1), 2022. e-Pub 2022. PMID: 36419072.
      32. Wu A, Huang RJ, Ruiz Colón G, Zembrzuski K, Patel CB. Low Rates of Structured Advance Care Planning Documentation in Electronic Health Records: Results of a Single-Center Observational Study. BMC Palliative Care, 2022. e-Pub 2022. PMID: 36419072.
      33. Ceran Y, Ergüder H, Ladner K, Korenfeld S, Deniz K, Padmanabhan S, Wong P, Baday M, Pengo T, Lou E, Patel CB. TNTdetect.AI: A deep learning model for automated detection and counting of tunneling nanotubes in microscopy images. Cancers, 2022. e-Pub 2022. PMID: 36230881.
      34. Arami H, Kananian S, Khalifehzadeh L, Patel CB, Chang E, Tanabe Y, Zeng Y, Madsen SJ, Mandella MJ, Natarajan A, Peterson EE, Sinclair R, Poon ASY, Gambhir SS. Remotely controlled near-infrared-triggered photothermal treatment of brain tumours in freely behaving mice using gold nanostar?s. Nat Nanotechnol, 2022. e-Pub 2022. PMID: 35995855.
      35. Sahan AZ, Baday M, Patel CB. Biomimetic Hydrogels in the Study of Cancer Mechanobiology: Overview, Biomedical Applications, and Future Perspectives. Gels 8(8):496, 2022. e-Pub 2022. PMID: 36005097.
      36. Shams S, Patel CB. Anti-cancer mechanisms of action of therapeutic alternating electric fields (tumor treating fields [TTFields]). J Mol Cell Biol, 2022. e-Pub 2022. PMID: 35973687.
      37. Moser JC, Salvador E, Deniz K, Swanson K, Tusynski J, Carlson KW, Karanam NK, Patel CB, Story M, Lou E, Hagemann C. The mechanisms of action of Tumor Treating Fields. Cancer Res, 2022. e-Pub 2022. PMID: 35839284.
      38. Reveron-Thornton R, Scott BJ, Post D, Caulfield AF, Werbaneth K, Hovsepian DA, Spiegel J, Miklos D, Thomas RP, Patel CB. Recurrent Status Epilepticus in the Setting of Chimeric Antigen Receptor (CAR)-T Cell Therapy. Neurohospitalist 12(1):74-79, 2022. e-Pub 2022. PMID: 34950390.
      39. Beinat C, Patel CB, Haywood T, Murty S, Naya L, Castillo JB, Reyes ST, Phillips M, Buccino P, Shen B, Park JH, Koran MEI, Alam IS, James ML, Holley D, Halbert K, Gandhi H, He JQ, Granucci M, Johnson E, Liu DD, Uchida N, Sinha R, Chu P, Born DE, Warnock GI, Weissman I, Hayden-Gephart M, Khalighi M, Massoud TF, Iagaru A, Davidzon G, Thomas R, Nagpal S, Recht LD, Gambhir SS. A Clinical PET Imaging Tracer ([18F]DASA-23) to Monitor Pyruvate Kinase M2-Induced Glycolytic Reprogramming in Glioblastoma. Clin Cancer Res 27(23):6467-6478, 2021. e-Pub 2021. PMID: 34475101.
      40. Kim KM, Tercan S, Baday M, Mahaney KB, Recht LD, Rajadas J, Patel CB. Electrophysiological Characterization of Glioma using a Biomimetic Spheroid Model. Proceedings of the 10th International IEEE/EMBS Conference on Neural Engineering (NER):86-89, 2021. e-Pub 2021.
      41. Dono A, Mitra S, Shah M, Takayasu T, Zhu JJ, Tandon N, Patel CB, Esquenazi Y, Ballester LY. PTEN mutations predict benefit from tumor treating fields (TTFields) therapy in patients with recurrent glioblastoma. J Neurooncol 153(1):153-160, 2021. e-Pub 2021. PMID: 33881725.
      42. Zhou, Q, Berg, NS, Rosenthal, EL, Iv, M, Zhang, M, Leonel, JC, Walters, S, Nishio, N, Granucci, M, Raymundo, R, Yi, G, Vogel, H, Cayrol, R, Lee, YJ, Lu, G, Hom, M, Kang, W, Hayden Gephart, MG, Recht, L, Nagpal, S, Thomas, R, Patel, C, Grant, GA, Li, G. EGFR-targeted intraoperative fluorescence imagin detects high-grade glioma with panitumumab-IRDye800 in a phase 1 clinical trial. Theranostics 11(15):7130-7143, 2021. e-Pub 2021. PMID: 34158846.
      43. Patel CB, Beinat C, Xie Y, Chang E, Gambhir SS. Tumor treating fields (TTFields) impairs aberrant glycolysis in glioblastoma as evaluated by [18F]DASA-23, a non-invasive probe of pyruvate kinase M2 (PKM2) expression. Neoplasia 23(1):58-67, 2021. e-Pub 2021. PMID: 33221711.
      44. Zhou Q, van den Berg NS, Rosenthal EL, Iv M, Zhang M, Vega Leonel JCM, Walters S, Nishio N, Granucci M, Raymundo R, Yi G, Vogel H, Cayrol R, Lee YJ, Lu G, Hom M, Kang W, Hayden Gephart M, Recht L, Nagpal S, Thomas R, Patel C, Grant GA, Li G. EGFR-targeted intraoperative fluorescence imaging detects high-grade glioma with panitumumab-IRDye800 in a phase 1 clinical trial. Theranostics 11(15):7130-7143, 2021. e-Pub 2021. PMID: 34158840.
      45. Sun J, Patel CB, Jang T, Merchant M, Chen C, Kazerounian S, Diers AR, Kiebish MA, Vishnudas VK, Gesta S, Sarangarajan R, Narain NR, Nagpal S, Recht L. High levels of ubidecarenone (oxidized CoQ10) delivered using a drug-lipid conjugate nanodispersion (BPM31510) differentially affect redox status and growth in malignant glioma versus non-tumor cells. Sci Rep 10(1):13899, 2020. e-Pub 2020. PMID: 32807842.
      46. Beinat C, Patel CB, Haywood T, Shen B, Naya L, Gandhi H, Holley D, Khalighi M, Iagaru A, Davidzon G, Gambhir SS. Human biodistribution and radiation dosimetry of [18F]DASA-23, a PET probe targeting pyruvate kinase M2. Eur J Nucl Med Mol Imaging 47(9):2123-2130, 2020. e-Pub 2020. PMID: 31938892.
      47. Murty S, Haile ST, Beinat C, Aalipour A, Alam IS, Murty T, Shaffer TM, Patel CB, Graves EE, Mackall CL, Gambhir SS. Intravital imaging reveals synergistic effect of CAR T-cells and radiation therapy in a preclinical immunocompetent glioblastoma model. Oncoimmunology 9(1):1757360, 2020. e-Pub 2020. PMID: 32923113.
      48. Beinat C, Patel CB, Xie Y, Gambhir SS. Evaluation of Glycolytic Response to Multiple Classes of Anti-glioblastoma Drugs by Noninvasive Measurement of Pyruvate Kinase M2 Using [18F]DASA-23. Mol Imaging Biol 22(1):124-133, 2020. e-Pub 2020. PMID: 30989436.
      49. Beinat C, Gowrishankar G, Shen B, Alam IS, Robinson E, Haywood T, Patel CB, Azevedo EC, Castillo JB, Ilovich O, Koglin N, Schmitt-Willich H, Berndt M, Mueller A, Zerna M, Srinivasan A, Gambhir SS. The Characterization of 18F-hGTS13 for Molecular Imaging of xC - Transporter Activity with PET. J Nucl Med 60(12):1812-1817, 2019. e-Pub 2019. PMID: 31171595.
      50. Haywood T, Beinat C, Gowrishankar G, Patel CB, Alam IS, Murty S, Gambhir SS. Positron emission tomography reporter gene strategy for use in the central nervous system. Proc Natl Acad Sci U S A 116(23):11402-11407, 2019. e-Pub 2019. PMID: 31123153.
      51. Aalipour A, Chuang HY, Murty S, D'Souza AL, Park SM, Gulati GS, Patel CB, Beinat C, Simonetta F, Martinic I, Gowrishankar G, Robinson ER, Aalipour E, Zhian Z, Gambhir SS. Engineered immune cells as highly sensitive cancer diagnostics. Nat Biotechnol 37(5):531-539, 2019. e-Pub 2019. PMID: 30886438.
      52. Arami H, Patel CB, Madsen SJ, Dickinson PJ, Davis RM, Zeng Y, Sturges BK, Woolard KD, Habte FG, Akin D, Sinclair R, Gambhir SS. Nanomedicine for Spontaneous Brain Tumors: A Companion Clinical Trial. ACS Nano 13(3):2858-2869, 2019. e-Pub 2019. PMID: 30714717.
      53. Natarajan A, Patel CB, Ramakrishnan S, Panesar PS, Long SR, Gambhir SS. A Novel Engineered Small Protein for Positron Emission Tomography Imaging of Human Programmed Death Ligand-1: Validation in Mouse Models and Human Cancer Tissues. Clin Cancer Res 25(6):1774-1785, 2019. e-Pub 2019. PMID: 30373750.
      54. Beinat C, Haywood T, Chen YS, Patel CB, Alam IS, Murty S, Gambhir SS. The Utility of [18F]DASA-23 for Molecular Imaging of Prostate Cancer with Positron Emission Tomography. Mol Imaging Biol 20(6):1015-1024, 2018. e-Pub 2018. PMID: 29736561.
      55. Patel CB, Fazzari E, Chakhoyan A, Yao J, Raymond C, Nguyen H, Manoukian J, Nguyen N, Pope W, Cloughesy TF, Nghiemphu PL, Czernin J, Lai A, Ellingson BM. 18F-FDOPA PET and MRI characteristics correlate with degree of malignancy and predict survival in treatment-naïve gliomas: a cross-sectional study. J Neurooncol 139(2):399-409, 2018. e-Pub 2018. PMID: 29679199.
      56. Patel CB, Trikamji BV, Mathisen GE, Mishra SK. Southern California neuroinvasive West Nile virus case series. Neurol Sci 39(2):251-257, 2018. e-Pub 2018. PMID: 29119349.
      57. Natarajan A, Patel CB, Habte F, Gambhir SS. Dosimetry Prediction for Clinical Translation of 64Cu-Pembrolizumab ImmunoPET Targeting Human PD-1 Expression. Sci Rep 8(1):633, 2018. e-Pub 2018. PMID: 29330552.
      58. Chang E, Patel CB, Pohling C, Young C, Song J, Flores TA, Zeng Y, Joubert LM, Arami H, Natarajan A, Sinclair R, Gambhir SS. Tumor treating fields increases membrane permeability in glioblastoma cells. Cell Death Discov 4:113, 2018. e-Pub 2018. PMID: 30534421.
      59. Chang E, Pohling C, Beygui N, Patel CB, Rosenberg J, Ha DH, Gambhir SS. Synergistic inhibition of glioma cell proliferation by Withaferin A and tumor treating fields. J Neurooncol 134(2):259-268, 2017. e-Pub 2017. PMID: 28681243.
      60. Chang TS, Patel CB, Keener AM, Keselman I, Jamal NI. Movements Here Today, Gone Tomorrow: Images in Clinical Neurology Case of Hyperglycemic Hemichorea. Neurohospitalist 7(3):150, 2017. e-Pub 2017. PMID: 28634509.
      61. Abdaljaleel M, Mazumder R, Patel CB, Im K, Pope W, Liau LM, Vinters HV, Yong WH. Multiple calcifying pseudoneoplasms of the neuraxis (MCAPNON): Distinct entity, CAPNON variant, or old neurocysticercosis?. Neuropathology 37(3):233-240, 2017. e-Pub 2017. PMID: 27862397.
      62. Kaufman DR, Sheehan B, Stetson P, Bhatt AR, Field AI, Patel C, Maisel JM. Natural Language Processing-Enabled and Conventional Data Capture Methods for Input to Electronic Health Records: A Comparative Usability Study. JMIR Med Inform 4(4):e35, 2016. e-Pub 2016. PMID: 27793791.
      63. Patel CB, Trikamji B, Mathisen G, Yim C, Zipser B, Mishra S. MRI Ventral Nerve Root Enhancement in Five Patients Presenting With Extremity Weakness Secondary to Neuroinvasive West Nile Virus. J Clin Neuromuscul Dis 18(1):41-3, 2016. e-Pub 2016. PMID: 27552389.
      64. Ferrell JK, Cattano D, Brown RE, Patel CB, Karni RJ. The effects of anesthesia on the morphoproteomic expression of head and neck squamous cell carcinoma: a pilot study. Transl Res 166(6):674-82, 2015. e-Pub 2015. PMID: 26423449.
      65. Haas EM, Nieto J, Ragupathi M, Aminian A, Patel CB. Critical appraisal of learning curve for single incision laparoscopic right colectomy. Surg Endosc 27(12):4499-503, 2013. e-Pub 2013. PMID: 23877765.
      66. Lambert EM, Patel CB, Fakhri S, Citardi MJ, Luong A. Optical rhinometry in nonallergic irritant rhinitis: a capsaicin challenge study. Int Forum Allergy Rhinol 3(10):795-800, 2013. e-Pub 2013. PMID: 23733747.
      67. Cattano, D, Gomez-Rivera, F, Seitan, C, Altamirano, A, Patel, C, Luong, A, Citardi, MJ, Fakhri, S, Hagberg, C. Post-operative effects. Journal of Anesthesia and Clinical Research 4(2), 2013. e-Pub 2013.
      68. Haas EM, Aminian A, Nieto J, Pedraza R, Martinez C, Patel CB, Pickron TB. Minimally Invasive Colorectal Surgery in the Morbidly Obese: Does High Body Mass Index Lead to Poorer Outcomes?. Surgery: Current Research 3(5):1-4, 2013. e-Pub 2013.
      69. Dominguez M, Perez JA, Patel CB. Efficacy of 3% saline vs. conivaptan in achieving hyponatremia treatment goals. Methodist Debakey Cardiovasc J 9(1):49-53, 2013. e-Pub 2013. PMID: 23519387.
      70. Cattano D, Ferrario L, Patel CB, Maddukuri V, Melnikov V, Gumbert SD, Altamirano AV, Hagberg CA. Utilization of C-MAC videolaryngoscopy for direct and indirect assisted endotracheal intubation. Journal of Anesthesiology and Clinical Science 2(10):1-5, 2013. e-Pub 2013.
      71. Tanios G, Aranguren IM, Goldstein JS, Patel CB. Diffuse large B-cell lymphoma: A metabolic disorder?. Am J Case Rep 14:518-25, 2013. e-Pub 2013. PMID: 24349605.
      72. Gomez-Rivera F, Cattano D, Ramaswamy U, Patel CB, Altamirano A, Man LX, Luong A, Chen Z, Citardi MJ, Fakhri S. Pilot study comparing total intravenous anesthesia to inhalational anesthesia in endoscopic sinus surgery: novel approach of blood flow quantification. Ann Otol Rhinol Laryngol 121(11):725-32, 2012. e-Pub 2012. PMID: 23193905.
      73. Cattano D, Corso RM, Altamirano AV, Patel CB, Meese MM, Seitan C, Hagberg CA. Clinical evaluation of the C-MAC D-Blade videolaryngoscope in severely obese patients: a pilot study. Br J Anaesth 109(4):647-8, 2012. e-Pub 2012. PMID: 22976864.
      74. Welsh KJ, Patel CB, Fernando RC, Torres JD, Medrek SK, Schnapp WB, Brown CA, Buck DS. Prevalence of bipolar disorder and schizophrenia in Houston Outreach Medicine, Education, and Social Services (HOMES) Clinic patients: implications for student-managed clinics for underserved populations. Acad Med 87(5):656-61, 2012. e-Pub 2012. PMID: 22450177.
      75. Patel CB, Strommen JJ, Elliott AM, Muallem G, Eissa MA. Nutrition Mission. Tex Med 108(4):e1, 2012. e-Pub 2012. PMID: 22714889.
      76. Kotha P, Patel CB, Vijayaraghavan K, Patel TG, Misra R. Modified criteria for determining cardiometabolic syndrome in Asian Indians living in the USA: report from the diabetes among Indian Americans national study. Int J Cardiol 155(2):343-5, 2012. e-Pub 2012. PMID: 22261694.
      77. Patel CB, Cattano D. Intraoperative conversion to open technique: is informed consent implied?. J Clin Ethics 23(1):60-7, 2012. e-Pub 2012. PMID: 22462385.
      78. Cattano D, Ferrario L, Patel CB, Normand KC, Seitan C, Hagberg CA. Laryngeal Tube Suction-D, Combitube, and Proseal Laryngeal Mask Airway: Randomized Clinical Trial. Journal of Anesthesiology and Clinical Science 1(8):1-6, 2012. e-Pub 2012.
      79. Cattano D, Gomez-Rivera F, Seitan C, Altamirano A, Patel CB, Luong A, Citardi M, Fakhri S, Hagberg CA. Post-Operative Effects: Comparison of Total Intravenous and Inhalational Anesthesia. Journal of Anesthesia & Clinical Research 4(287):1-4, 2012. e-Pub 2012.
      80. Cattano D, Gomez-Rivera F, Seitan C, Altamirano AV, Patel CB, Luong AU, Citardi MJ, Fakhri S, Hagberg CA. Platelet Function as Affected by Total Intravenous and Inhalational Anesthesia. Journal of Anesthesia & Clinical Research 4(290):1-6, 2012. e-Pub 2012.
      81. Ramos-Valadez DI, Ragupathi M, Nieto J, Patel CB, Miller S, Pickron TB, Haas EM. Single-incision versus conventional laparoscopic sigmoid colectomy: a case-matched series. Surg Endosc 26(1):96-102, 2012. e-Pub 2012. PMID: 21792717.
      82. Pedraza R, Patel CB, Ramos-Valadez DI, Haas EM. Robotic-assisted laparoscopic surgery for restorative proctocolectomy with ileal J pouch-anal anastomosis. Minim Invasive Ther Allied Technol 20(4):234-9, 2011. e-Pub 2011. PMID: 21417830.
      83. Ramos-Valadez DI, Patel CB, Ragupathi M, Bokhari MB, Pickron TB, Haas EM. Single-incision laparoscopic colectomy: outcomes of an emerging minimally invasive technique. Int J Colorectal Dis 26(6):761-7, 2011. e-Pub 2011. PMID: 21445554.
      84. Cattano D, Valleggi S, Cavazzana AO, Patel CB, Ma D, Giunta F. Xenon exposure in the neonatal rat brain: effects on genes that regulate apoptosis. Minerva Anestesiol 77(6):571-8, 2011. e-Pub 2011. PMID: 21617619.
      85. Bokhari, MB, Patel, C, Ramos-Valadez, DI, Ragupathi, M, Haas, EM. Learning curve for robotic-assisted laparoscopic colorectal surgery. Surgical endoscopy 25(3):855-860, 2011. e-Pub 2011. PMID: 20734081.
      86. Patel CB, Ragupathi M, Ramos-Valadez DI, Haas EM. A three-arm (laparoscopic, hand-assisted, and robotic) matched-case analysis of intraoperative and postoperative outcomes in minimally invasive colorectal surgery. Dis Colon Rectum 54(2):144-50, 2011. e-Pub 2011. PMID: 21228660.
      87. Patel CB, Ragupathi M, Bhoot NH, Pickron TB, Haas EM. Patient satisfaction and symptomatic outcomes following stapled transanal rectal resection for obstructed defecation syndrome. J Surg Res 165(1):e15-21, 2011. e-Pub 2011. PMID: 21067778.
      88. Gandhi DP, Ragupathi M, Patel CB, Ramos-Valadez DI, Pickron TB, Haas EM. Single-incision versus hand-assisted laparoscopic colectomy: a case-matched series. J Gastrointest Surg 14(12):1875-80, 2010. e-Pub 2010. PMID: 20922576.
      89. Patel CB, Ramos-Valadez DI, Haas EM. Robotic-assisted laparoscopic abdominoperineal resection for anal cancer: feasibility and technical considerations. Int J Med Robot 6(4):399-404, 2010. e-Pub 2010. PMID: 20827795.
      90. Patel CB, Ramos-Valadez DI, Ragupathi M, Haas EM. Single incision laparoscopic-assisted right hemicolectomy: technique and application (with video). Surg Laparosc Endosc Percutan Tech 20(5):e146-9, 2010. e-Pub 2010. PMID: 20975489.
      91. Ramos-Valadez DI, Patel CB, Ragupathi M, Bartley Pickron T, Haas EM. Single-incision laparoscopic right hemicolectomy: safety and feasibility in a series of consecutive cases. Surg Endosc 24(10):2613-6, 2010. e-Pub 2010. PMID: 20364353.
      92. Patel CB, Rashid RM, Nguyen TH. Management of extensive squamous cell carcinoma on the site of radiation-induced dermatitis with severe fibrosis: a case report. Journal of Radiotherapy in Practice 9(2):125-128, 2010. e-Pub 2010.
      93. Ragupathi M, Patel CB, Ramos-Valadez DI, Haas EM. Robotic-assisted laparoscopic "salvage" rectopexy for recurrent ileoanal J-pouch prolapse. Gastroenterol Res Pract 2010:790462, 2010. e-Pub 2010. PMID: 20414343.
      94. Patel CB, Cohen DM, Ahobila-Vajjula P, Sundberg LM, Chacko T, Narayana PA. Effect of VEGF treatment on the blood-spinal cord barrier permeability in experimental spinal cord injury: dynamic contrast-enhanced magnetic resonance imaging. J Neurotrauma 26(7):1005-16, 2009. e-Pub 2009. PMID: 19226205.
      95. Cohen DM, Patel CB, Ahobila-Vajjula P, Sundberg LM, Chacko T, Liu SJ, Narayana PA. Blood-spinal cord barrier permeability in experimental spinal cord injury: dynamic contrast-enhanced MRI. NMR Biomed 22(3):332-41, 2009. e-Pub 2009. PMID: 19023867.
      96. O'Daniel JC, Rosenthal DI, Garden AS, Barker JL, Ahamad A, Ang KK, Asper JA, Blanco AI, de Crevoisier R, Holsinger FC, Patel CB, Schwartz DL, Wang H, Dong L. The effect of dental artifacts, contrast media, and experience on interobserver contouring variations in head and neck anatomy. Am J Clin Oncol 30(2):191-8, 2007. e-Pub 2007. PMID: 17414470.
      97. Sherman DL, Patel CB, Zhang N, Rossell LA, Tsai YC, Thakor NV, Mirski MA. Sinusoidal modeling of ictal activity along a thalamus-to-cortex seizure pathway I: new coherence approaches. Ann Biomed Eng 32(9):1252-64, 2004. e-Pub 2004. PMID: 15493512.
      98. Patel CB, Sherman DL, Paul JS, Zhang N, Mirski MA. Residual entropy reveals effects of deep brain stimulation on neural activity in PTZ-induced epilepsy. Proceedings of the 25th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBS) 3:2281-2284, 2003. e-Pub 2003.
      99. Paul JS, Patel CB, Al-Nashash H, Zhang N, Ziai WC, Mirski MA, Sherman DL. Prediction of PTZ-induced seizures using wavelet-based residual entropy of cortical and subcortical field potentials. IEEE Trans Biomed Eng 50(5):640-8, 2003. e-Pub 2003. PMID: 12769440.
      100. Paul JS, Patel CB, Asari VK, Sherman DL. Unbiased frequency estimation of narrowband signals using Procrustes type subspace rotation. Proceedings of the 27th IEEE International Conference on Acoustics, Speech, and Signal Processing (ICASSP):II-1693-II-1696, 2002. e-Pub 2002.
      101. Loeb DM, Evron E, Patel CB, Sharma PM, Niranjan B, Buluwela L, Weitzman SA, Korz D, Sukumar S. Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation. Cancer Res 61(3):921-5, 2001. e-Pub 2001. PMID: 11221883.

      Review Articles

      1. Pohling, C, Nguyen, H, Chang, E, Schubert, KE, Nie, Y, Bashkirov, V, Yamamoto, V, Zeng, Y, Stupp, R, Schulte, R, Patel, C. Current status of the preclinical evaluation of alternating electric fields as a form of cancer therapy. Bioelectrochemistry 149, 2023. e-Pub 2023. PMID: 36306728.
      2. Fite, BZ, Hinostroza, V, States, L, Hicks-Nelson, A, Baratto, L, Kallianos, K, Codari, M, Yu, B, Jha, P, Shams, M, Stoyanova, T, Chapelin, FF, Liu, A, Rashidi, A, Soto, F, Quintana, Y, Davidzon, G, Marycz, K, Gibbs, IC, Chonde, DB, Patel, C, Daldrup-Link, HE. Increasing Diversity in Radiology and Molecular Imaging. Molecular Imaging and Biology 23(5):625-638, 2021. e-Pub 2021. PMID: 33903986.
      3. Wu A, Ruiz Colón G, Aslakson R, Pollom E, Patel CB. Palliative Care Service Utilization and Advance Care Planning for Adult Glioblastoma Patients: A Systematic Review. Cancers (Basel) 13(12), 2021. e-Pub 2021. PMID: 34201260.
      4. Aguilar AA, Ho MC, Chang E, Carlson KW, Natarajan A, Marciano T, Bomzon Z, Patel CB. Permeabilizing Cell Membranes with Electric Fields. Cancers (Basel) 13(9), 2021. e-Pub 2021. PMID: 34068775.
      5. Li D, Patel CB, Xu G, Iagaru A, Zhu Z, Zhang L, Cheng Z. Visualization of Diagnostic and Therapeutic Targets in Glioma With Molecular Imaging. Front Immunol 11:592389, 2020. e-Pub 2020. PMID: 33193439.
      6. Daye, D, Patel, C, Ahn, J, Nguyen, FT. Challenges and opportunities for reinvigorating the physician-scientist pipeline. Journal of Clinical Investigation 125(3):883-887, 2015. e-Pub 2015. PMID: 25689260.
      7. Amini B, Patel CB, Lewin MR, Kim T, Fisher RE. Diagnostic nuclear medicine in the ED. Am J Emerg Med 29(1):91-101, 2011. e-Pub 2011. PMID: 20825918.
      8. Ragupathi M, Ramos-Valadez DI, Patel CB, Haas EM. Robotic-assisted laparoscopic surgery for recurrent diverticulitis: experience in consecutive cases and a review of the literature. Surg Endosc 25(1):199-206, 2011. e-Pub 2011. PMID: 20567850.
      9. Patel CB, Rashid RM. Averting the proliferation of acronymophilia in dermatology: effectively avoiding ADCOMSUBORDCOMPHIBSPAC. J Am Acad Dermatol 60(2):340-4, 2009. e-Pub 2009. PMID: 19150279.

      Other Articles

      1. Tatsui CE, Carlson KW, Patel CB Tumor Treating Fields (TTFields) for Spinal Metastasis - the Case for Bone Removal and Spinal Implants as Waveguides to Enhance Field Strength at the Target. Neuro-Oncology Advances, 2024. PMID: 38288093.
      2. Patel, C Cultural humility in medicine. Texas medicine 102(4):7, 2006. PMID: 17128753.

      Editorials

      1. Hacohen Y, Patel CB, Hintzen R. A single demyelinating attack is enough to limit brain growth in children. Neurology 88(18):1691-1692, 2017. PMID: 28381511.

      Abstracts

      1. Cao, T, Gu, Y, Yagmurlu, B, Yerraballa, HP, Bertrand, S, Naya, L, Miller, K, Iv, M, Soltys, SG, Patel, C, Nagpal, S, Thomas, R, Brown, M, Recht, L. A phase II study of plerixafor combined with whole brain radiation therapy (WBRT) for patients with newly diagnosed glioblastoma. American Society for Clinical Oncology 42:2075, 2024. e-Pub 2024.
      2. Majd, NK, Yeboa, DN, Wang, S, Weathers, S, Yuan, Y, Al Anssari, H, Kamiya Matsuoka, C, O'Brien, BJ, Aaroe, AE, Patel, C, Dagher, SA, Wintermark, M, Ferguson, SD, Puduvalli, VK, Liu, SJ, Raleigh, D, de Groot, JF. Phase I clinical trial of peposertib plus radiation in adults with newly diagnosed MGMT-unmethylated glioblastoma. American Society for Clinical Oncology 42(16_suppl):2076, 2024. e-Pub 2024.
      3. Nguyen H, Zeng Y, Pohling C, Bashkirov V, Nie Y, Chang E, Yamamoto V, Schubert K, Patel CB, Schulte R. Finite Element Analysis of Customized Alternating Electric Fields Transducers for Small Animal Applications. The American Association of Physicists in Medicine (AAPM) 49(6):E773, 2022. e-Pub 2022.
      4. Patel CB, Kattepogu KM, Park IJ, Eng C, Delclos ME, Feig BW, Crane CH, Skibber JM, Das P, Rodriguez-Bigas MA, Krishnan S, Chang GJ. Impact of preoperative radiation dose escalation on pathologic outcomes and radiation toxicity in locally advanced rectal cancer (LARC): A matched-pair analysis. Journal of Clinical Oncology 29(15_suppl), 2011. e-Pub 2011.
      5. Po MJ, Lin R, Chen B, Patel CB, Awon J, Allen L, Lantz J, Gerber AJ. Developing a Novel Therapeutic Game for Children with Autism Spectrum Disorder. First AMA-IEEE Conference on Medical Technology 1(1), 2010. e-Pub 2010.
      6. Patel CB, Wang H, Zhang J, Dong L. 3D Probability Distribution of Treatment Targets: A New Way to Define 3D Organ Motion for Prostate Cancer Radiotherapy. International Journal of Radiation Oncology*Biology*Physics, 2005. e-Pub 2005. PMID: 16265758.

      Letters to the Editor

      1. Patel CB. From Subsistence to Sustenance in Physician-Scientist Training. Acad Med 93: 521, 2018.
      2. Peiris AN, Patel CB. Predictive analytics: the fifth clinical element. South Med J 106: 290-1, 2013.
      3. Patel CB, Schauberger EM, Nguyen FT. Toward a better understanding of the retention of physician-scientists in the career pipeline. Acad Med 87: 390-1; author reply 391, 2012.
      4. Patel CB. Consider using diffusion tensor imaging in Geron phase I trial. AJNR Am J Neuroradiol 30: E97, 2009.
      5. Patel CB. Letter by Patel regarding article, "A primer in longitudinal data analysis". Circulation 120: e25, 2009.

      Patents

      1. Using alternating electric fields to increase cell membrane permeability. Patent Number: US11103698B2.
      Read More
      Less

      Patient Reviews


      CV information above last modified July 22, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top